Valuation: Waldencast plc

Market Cap 105M 93.27M 87.05M 79.35M 150M 10.09B 151M 1.05B 408M 5.16B 394M 386M 16.56B P/E 2026 *
-1.76x
P/E 2027 * -2x
Enterprise Value 105M 93.27M 87.05M 79.35M 150M 10.09B 151M 1.05B 408M 5.16B 394M 386M 16.56B EV / Sales 2026 *
0.37x
EV / Sales 2027 * 0.33x
Free-Float
44.64%
Yield 2026 *
-
Yield 2027 * -
09-24 Waldencast Files to Delist Shares, Warrants From Nasdaq MT
09-20 Waldencast plc(NasdaqCM:WALD) added to S&P Global BMI Index CI
09-14 Top Premarket Decliners MT
09-14 Waldencast Plans Voluntary Nasdaq Delisting; Shares Down Pre-Bell MT
07-29 Bridgepoint Europe VII and Bridgepoint Europe VII 2 LP, funds managed by Bridgepoint Advisers Limited, and Gore Range Capital Fund III Llc, a fund managed by Gore Range Capital LLC, acquired Obagi Cosmeceuticals LLC, Obagi Netherlands B.V. and Obagi AsiaPac Limited from Waldencast plc. CI
06-15 Waldencast plc Announces Fda Approval of Obagi Saypha Chiq Injectable Hyaluronic Acid Gel CI
06-15 Waldencast Says US FDA Approves Obagi Saypha ChIQ Injectable Hyaluronic Acid Gel MT
06-01 Waldencast plc Announces CEO Changes CI
06-01 Waldencast plc Announces Board Changes, Effective June 1, 2026 CI
06-01 Waldencast announces sale of Obagi Medical to Bridgepoint RE
05-31 Bridgepoint Europe VII and Bridgepoint Europe VII 2 LP, funds managed by Bridgepoint Advisers Limited, and Gore Range Capital Fund III Llc, a fund managed by Gore Range Capital LLC, entered into a definitive agreement to acquire Obagi Cosmeceuticals LLC, Obagi Netherlands B.V. and Obagi AsiaPac Limited from Waldencast plc for $460 million. CI
05-15 Obagi Medical Shares New Data on Recent Innovations At Music City Symposium for Cosmetic Advances and Laser Education Meeting CI
05-14 Obagi Medical And Next Health Form Strategic Alliance To Launch The Skin Recharge Station Pop-Up Experience CI
1 day-12.48%
1 week-9.93%
Current month+7.93%
1 month-31.28%
3 months-44.78%
6 months+3.22%
Current year-50.65%
1 week 0.82
Extreme 0.82
1.06
1 month 0.82
Extreme 0.82
1.38
Current year 0.72
Extreme 0.72
2.01
1 year 0.72
Extreme 0.72
3.22
3 years 0.72
Extreme 0.72
12
5 years 0.72
Extreme 0.72
12.1
10 years 0.72
Extreme 0.72
12.1
Manager TitleAgeSince
Chief Executive Officer 60 29/07/2026
General Counsel - 31/08/2023
Director TitleAgeSince
Chairman 60 31/12/2020
Director/Board Member 60 30/11/2021
Director/Board Member 52 28/02/2021
Date Insider Type Main position Quantity % Market Cap. Importance
28/08/26
Zeno Equity Partners LLP
BuyCompany 335,000 0.2774%
30/07/26 Exercice

Chief Financial Officer

158,578 0.1313%
30/07/26 Issuer sale

Founder

-193,816 0.1605%
Change 5-day change 1-year change 3-year change Capi.($)
-12.48%-9.93%-50.39%-90.14% 105M
-2.04%-1.03%+30.33%+60.50% 32.82B
-2.23%-1.91%-41.26%+544.49% 24.96B
+1.11%-0.28%-2.53%+34.93% 23.25B
-2.02%-3.66%-44.71%-23.61% 16.2B
+0.33%-2.16%-22.79% - 15.81B
+2.43%-0.26%-40.94%+28.02% 12.1B
-0.90%-1.12%+28.38% - 11.18B
-0.88%-2.40%-24.18%+152.78% 9.08B
+2.54%-0.55%-53.71%-2.26% 7.3B
Average -1.41%-1.78%-22.18%+88.09% 15.28B
Weighted average by Cap. -0.63%-0.98%-12.91%+140.73%

Financials

2026 *2027 *
Net sales 287M 255M 238M 217M 409M 27.55B 412M 2.88B 1.11B 14.08B 1.08B 1.05B 45.2B 318M 282M 263M 240M 453M 30.53B 457M 3.19B 1.23B 15.61B 1.19B 1.17B 50.09B
Net income -57.81M -51.36M -47.94M -43.69M -82.4M -5.56B -83.17M -580M -225M -2.84B -217M -212M -9.12B -51.81M -46.04M -42.97M -39.16M -73.86M -4.98B -74.55M -520M -201M -2.55B -195M -190M -8.17B
Net Debt - -
Logo Waldencast plc
Waldencast plc is a global multi-brand beauty and wellness platform. It is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. The Obagi Medical segment sells advanced skincare products backed by science and formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and to protect and enhance skin tone and texture. Its portfolio of medical-grade skincare with consumer-centric, in-office injectable procedures includes Saypha ChIQ, and MagIQ lines of injectable hyaluronic acid gels. The Milk Makeup segment consists of the business of Milk. Its Milk’s business activities include developing, marketing, and selling cosmetics, skincare, and other beauty products. Its Milk Makeup segment offers over 250 products through its United States Website www.MilkMakeup.com and retail partners include Sephora globally and Ulta Beauty in the United States.
Employees
367
Date Price Change Volume
02/10/26 US$0.8794 -4.69% 277,019
01/10/26 US$0.9227 +7.35% 305,016
30/09/26 US$0.8595 -7.35% 289,924
29/09/26 US$0.9277 -12.48% 287,905
28/09/26 US$1.060 +2.91% 265,578
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.8794USD
Average target price
2.050USD
Spread / Average Target
+133.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. WALD Stock